This program focuses on the role of abacavir, a nucleoside reverse transcriptase inhibitor, in treating human immunodeficiency virus 1 (HIV-1) infection when combined with other antiretroviral agents. This course explores the indications, dosing schedules, contraindications, and potential adverse effects of abacavir use. Antiretroviral therapy is a critical factor in achieving favorable outcomes for HIV patients, and this program places a significant emphasis on the importance of treatment adherence and the prevention of drug resistance.
Copyright © 2024, StatPearls Publishing LLC.